Dr. Daniel D'Amore, MD

Dr. D'Amore practices at Singing River Gulfport in Gulfport, Mississippi, part of State of Mississippi.

Dr. D'Amore's NPI, 1174673248, was assigned on January 11, 2007. Dr. D'Amore graduated from University of Miami, Miller School of Medicine in 2002. Dr. D'Amore holds Florida license TRN6245.

Dr. D'Amore's primary practice is Singing River Gulfport, at 15200 Community Road, Gulfport, MS 39503 in Harrison County. The practice phone is (228) 575-7000.

Dr. D'Amore's primary practice is Singing River Gulfport in Gulfport, Mississippi, part of State of Mississippi. Dr. D'Amore is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is Mississippi Emergency Department Services (MEDS). Dmand AI also links Dr. D'Amore to 4 more hospitals, 5 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. D'Amore practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. D'Amore's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. D'Amore is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. D'Amore's licenses on file in 6 states: Florida, Georgia, Mississippi, Delaware, South Carolina and Wyoming.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, chronic kidney disease, chronic respiratory failure, circulation problems, coronary artery disease, intermittent racing heartbeat (PSVT) and sick sinus syndrome among the conditions Dr. D'Amore treats.

CMS data shows 606 Medicare services from Dr. D'Amore across 4 procedure codes in 2024, for 449 Medicare patients. Medicare paid $59,694 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 449 Medicare patients who saw Dr. D'Amore in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. D'Amore's median patient age at 56, with 57% women.

In 2024, Dr. D'Amore wrote 238 Medicare Part D claims for 160 patients. 92% of them were for generic drugs. CMS names the drug for 100 of them, across 6 drugs with 11 or more claims each, at $525 in total drug cost. In 2023, CMS named 109 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. D'Amore for performance year 2024, reported as part of a group. Dr. D'Amore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 108 general payments to Dr. D'Amore from 9 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 63% of the total. Pfizer Inc. paid the most, $20,127.

Dr. D'Amore graduated from University of Miami, Miller School of Medicine in 2002.

Dr. D'Amore is in network with 11 carriers, including Excellus BlueCross BlueShield, United Healthcare and Alliant Health Plans. Medicaid plans come from the most carriers, 4. Check the plan with the practice before a visit.